Innovation

Laborum Voluptatem

Ut aliqua Dolore alias recusandae Id libero voluptatem dolore sunt saepe quis cupiditate dolor dolor duis nulla amet

vikas new | Nov 03, 1985

new auth way

s simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since 1966, when designers at Letraset and James Mosley, the librarian at St Bride Printing Library in London, took a 1914 Cicero translation and scrambled it to make

Ankit Kankar | Jun 20, 2026

Research & development

& kedar

Samie Ahmed | May 19, 2026

Telangana Life Sciences Ecosystem Reaches $145 Billion Valuation After Rs. 84,000 Crore Investment Surge

Telangana's life sciences sector hits $145B valuation on Rs. 84,000 crore investment, reshaping India's API and CDMO supply landscape.

Dr. Vaishali Atri | Jun 24, 2026

Cipla Gains First AB-Rated gVentolin Approval in U.S. Respiratory Generics Market

Cipla secures the first AB-rated gVentolin approval in the U.S., clearing the FDA's complex pMDI equivalence threshold while posting record FY26 revenue.

Michael Bani | May 15, 2026

Alembic Pharma Gains USFDA Tentative Approval for Darolutamide Tablets in U.S. Oncology Market

Alembic Pharma secures USFDA tentative approval for Darolutamide Tablets 300 mg, targeting a $3.155B U.S. oncology generic market.

Michael Bani | May 15, 2026

Indoco Remedies Gains EU GMP Certification for Baddi Plant from Malta Medicines Authority

Indoco Remedies' Baddi plant receives EU GMP certification from Malta Medicines Authority after a five-day inspection in early 2026.

Michael Bani | May 15, 2026